For Women, Help but Also Risk

New York Times - Prozac’s introduction by Eli Lilly and Company in 1988 transformed not only the treatment of depression but also our views and expectations of pharmaceuticals. But was it a true step forward in medicine, or did it just open the flood gates to aggressive marketing and commercial branding of drugs? Lisa Schwartz and Steve Woloshin, professors of medicine and codirectors of the Center for Medicine in the Media at the Dartmouth Institute for Health Policy and Clinical Practice, participate in a debate. Read more...